The disease is too complex, experts argue. But drugmakers are still hoping for a foot in that lucrative door. In other pharmaceutical news: insulin drug pricing, pharmacy benefits managers, postpartum depression drugs, a rare genetic disease, and more.
from Kaiser Health News https://ift.tt/2TrTYrD
March 25, 2019
Rose
Health News, Kaiser Health News
No comments
Related Posts:
New California Law Offers Fresh Protection From Steep Ambulance BillsLast year, Jennifer Reisz’s college-age daughter, Megan, was kicked in the chest multiple times by the family’s horse. Megan fell to the ground, unable to move or speak. Though she was alone, her Apple Watch detected her dist… Read More
Science Says Teens Need More Sleep. So Why Is It So Hard to Start School Later?NASHVILLE, Tenn. — High school classes start so early around this city that some kids get on buses at 5:30 in the morning. Just 10% of public schools nationwide start before 7:30 a.m., according to federal statistics. But in … Read More
States Reconsider Religious Exemptions for Vaccinations in Child CareMore than half the children who attend Munchkin Land Daycare near Billings, Montana, have special needs or compromised immune systems. The kids, who range in age from 4 months to 9 years, have conditions that include fetal al… Read More
Epidemic: The Scars of Smallpox In 1975, smallpox eradication workers in the capital of Bangladesh, Dhaka, rushed to Kuralia, a village in the country’s south. They were abuzz and the journey was urgent because they thought they just might get to document… Read More
Nursing Homes Say They Can’t Afford Higher Staffing. But Their Finances Are Often Opaque.Perhaps the biggest mystery, as the Biden administration moves to force nursing homes to boost staffing, is this: how much extra money do the nation’s 15,000 homes actually have to hire and retain more nurses and aides? Publi… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment